New perspectives in the measurement of cardiovascular risk: Explorations to detect sublicinical atherosclerosis and inflammation markers;Nuevas perspectivas en la medición del riesgo cardiovascular: Exploraciones para detectar la aterosclerosis subclínica y marcadores de inflamación

Medicina Clinica

Volumn 128, Issue 9, 2007, Pages 344-351

  Fernández Miranda, Consuelo ^a   Pinto Sala X ^b   Carreras, Francesc ^c   Civeira, Fernando ^d   Fabiani, Fernando ^e   Lahoz, Carlos ^f   Masana, Luis ^g   Garrido, Juan Antonio ^h   Santos, Pedro González ⁱ   Millán, Jesús ^j   Panisello, Joima ^k   Ros, Emilio ^l  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^h Universidad de La Coruña   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^j HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^k Fundación para El Fomento de la Innovación Industrial FFII   (Spain)

^l HOSPITAL CLÍNIC   (Spain)

more..

Author keywords

Ankle brachial index; Carotid ultrasonography; Computed tomography; Coronary calcifications; Subclinical atherosclerosis

Indexed keywords

C REACTIVE PROTEIN; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID;

ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; CALCIFICATION; CARDIOVASCULAR RISK; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INFLAMMATION; MEDICAL SOCIETY; PROGNOSIS; REVIEW;

EID: 34247098037     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13099803     Document Type: Review

References (68)

1. Third Report on the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
2. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003.
3. Mostaza JM, Vicente I, Cairols M, Castillo J, González-Juanatey JR, Pomar JL, et al. Indice tobillo brazo y riesgo cardiovascular. Med Clin (Barc). 2003;121:68-73.
4. Fowkes FG. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol. 1988;17:248-54.
5. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961-5.
6. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993;88:837-45.
7. Zheng ZJ, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 1997;131:115-25.
8. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997;2:221-6.
9. McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119-28.
10. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-6.
11. Vogt MT, Cauley JA, Newman AB, Kuller LH, Hulley SB. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA. 1993;270:465-9.
12. Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ. 1996;313:1440-4.
13. Abbott RD, Petrovitch H, Rodriguez BL, Yano K, Schatz IJ, Popper JS, et al. Ankle/brachial blood pressure in men > 70 years of age and the risk of coronary heart disease. Am J Cardiol. 2000;86:280-4.
14. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19:538-45.
15. Abbott RD, Rodriguez BL, Petrovitch H, Yano K, Schatz IJ, Popper JS, et al. Ankle-brachial blood pressure in elderly men and the risk of stroke: the Honolulu Heart Program. J Clin Epidemiol. 2001;54:973-8.
16. Tsai AW, Folsom AR, Rosamond WD, Jones DW. Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study. Stroke. 2001;32:1721-4.
17. Ogren M, Hedblad B, Isacsson SO, Janzon L, Jungquist G, Lindell SE. Ten year cerebrovascular morbidity and mortality in 68 year old men with asymptomatic carotid stenosis. BMJ. 1995;310:1294-8.
18. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol. 1999;19:617-24.
19. Kornitzer M, Dramaix M, Sobolski J, Degre S, De Backer G. Ankle/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality. Angiology. 1995;46:211-9.
20. O'Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation. 2006;113:388-93.
21. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation. 2004;109:733-9.
22. Vicente I, Lahoz C, Taboada M, García A, San Martín MA, Terol I, et al. Prevalencia de un indice tobillo-brazo patológico según el riesgo cardiovascular calculado mediante la función de Framingham. Med Clin (Barc). 2005;124:641-4.
23. Lahoz C, Vicente I, Taboada M, Laguna F, García-lglesias F, Mostaza JM. Índice tobillo-brazo y riesgo cardiovascular estimado mediante la función de SCORE en sujetos no diabéticos en prevención primaria. Clin Invest Arterioscler. 2006 [en prensa].
24. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;10:E16-22.
25. Chambless LE, Folsom AR, Davis V, Sharrett R, Heiss G, Sorlie P, et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol. 2002;155:38-47.
26. Junyent M, Gilabert R, Núñez I, Corbella E, Vela M, Zambon D, et al. Ecografía carotídea en la evaluación de aterosclerosis preclínica. Distribución de valores del grosor íntima-media y frecuencia de placas de ateroma en una cohorte comunitaria española. Med Clin (Barc). 2005;125: 770-4.
27. Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke. 1997;28:518-25.
28. Graner M, Varpula M, Kahri J, Salonen RM, Nyyssonen K, Nieminen MS, et al. Association of carotid intima-media thickness with angiographic severity and extent of coronary artery disease. Am J Cardiol. 2006;97:624-9.
29. Ogata T, Yasaka M, Yamagishi M, Seguchi O, Nagatsuka K, Minematsu K. Atherosclerosis found on carotid ultrasonography is associated with atherosclerosis on coronary intravascular ultrasonography. J Ultrasound Med. 2005;24:469-74.
30. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96:1432-7.
31. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14-22.
32. Espeland MA, O'Leary DH, Terry JG, Morgan T, Evans G, Mudra H. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med. 2005;6:3.
33. Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke. 2004;35:2902-9.
34. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, et al; Advisory Board of the 3rd Watching the Risk Symposium 2004, 13th European Stroke Conference. Mannheim intima-media thickness consensus. Cerebrovasc Dis. 2004;18:346-9.
35. Civeira F; International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004;173:55-68.
36. Bernard S, Serusclat A, Targe F, Charriere S, Roth O, Beaune J, et al. Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care. 2005;28:1158-62.
37. De Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart JC, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation. 2004;109 Suppl 1:33-8.
38. Wayhs R, Zelinger A, Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol. 2002;39:225-30.
39. LaMont DH, Budoff MJ, Shavelle DM, Shavelle R, Brundage BH, Hogar JM. Coronary calcium scanning adds incremental value to patients with positive stress tests. Am Heart J. 2002;143:861-7.
40. Park R, Detrano R, Xiang M, Fu P, Ibrahim Y, LaBree L, et al. Combined use of computed tomography coronary calcium scores and C-Reactive Protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation. 2002;106:2073-7.
41. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-32.
42. Rumberger JA, Brundage BH, Rader DJ, Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999;74:243-52.
43. Morin RL, Gerber TC, McCollough C. Radiation dose in computed tomography of the heart. Circulation. 2003;107:917-22.
44. Hunold P, Vogt FM, Schmermund A, Debatin JF, Kerkhoff G, Budde T, et al. Radiation exposure during cardiac CT: effective doses at multi-detector row CT and electron-beam CT. Radiology. 2003;226:145-52.
45. Georgiu D, Budoff MJ, Kaufer E, Kennedy JM, Lu B, Brundage BH. Screening patients with chest pain in the emergency department using electron beam tomography: a follow-up study. J Am Coll Cardiol. 2001;38:105-10.
46. Leber AW, Knez A, Becker A, Becker C, Von Ziegler F, Nikolaou K, et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J Am Coll Cardiol. 2004;43:1241-7.
47. Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106:1308-9.
48. Clarke SE, Beletsky V, Hammond RR, Hegele RA, Rutt BK. Validation of automatically classified magnetic resonance images for carotid plaque compositional analysis. Stroke. 2006;37:93-7.
49. Lipinski MJ, Fuster V, Fisher EA, Fayad ZA. Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging. Nat Clin Pract Cardiovasc Med. 2004;1:48-55.
50. Harvey S. Hecht MD and Society of Atherosclerosis Imaging. Practice guidelines for electron beam tomography: a report of the Society of Atherosclerosis Imaging. Am J Cardiol. 2000;86:705-6.
51. Shaw L, Raggi P, Callister TQ. Establishing cost effective thresholds for coronary disease screening: a predictive model with risk factors and coronary calcium. Prog Cardiovasc Dis. 2003;46:171-84.
52. Screening for Heart Attack Prevention and Education (SHAPE) Task Force report [citado 15 Mar 2006]. Disponible en: www.VP.org; www.AEHA.org
53. Carreras F. Detection and quantification of coronary artery calcium by MDCT. En: Pons-Lladó G, Leta R, editores. Atlas of non-invasive coronary angiography by multislice computed tomography (MSCT). New York: Springer-Verlag; 2006 [en prensal.
54. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-26.
55. Tracey RP. Inflammation in cardiovascular disease. Circulation. 1998; 97: 200-2.
56. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol. 2001;88.10K-15K
57. Sakkinen P, Abbott RD, Curb DJ Rodríguez BL, Yano K, Tracy RP. C-reactive protein and myocardial infarction. J Clin Epidemiol. 2002;55:445-51.
58. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low density lipoprotein colesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-65.
59. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al. C-reactive protein ond other circulating markers of infammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-97.
60. Wilson PWF, Nam BH, Pencina M, D'Agostino RB Sr, Benjamin EJ, O'Donnell CJ. C-reactive Protein and risk of cardiovascular disease in Men and Women from the Framingham Heart Study. Arch Intern Med. 2005;165:2473-8.
61. Ridker PM. Clinical application of C-Reactive Protein for cardiovascular disease detection and prevention. Circulation. 2003;107;363-9.
62. Sabatine MS, Morrow DA, De Lemos JA Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Simultaneous assessment of troponin I, C-reactive protein and B-type natriuretic peptide. Circulation. 2002;105:1760-3.
63. Bodi V, Sanchis J, Llacer A, Nuñez J, Facila L, Pellicer M et al. Valor independiente de la proteina C reactiva para predecir acontecimientos mayores al primer mes y al año en los síndromes coronarios agudos sin elevación del ST. Med Clin (Barc). 2004;122:248-52.
64. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20-8.
65. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, et al. Reversal of Atherosclerosis with Aggressive Lipid Lowerin (REVERSAL) Investigators. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005;352:29-38.
66. Bustos C, Hernandez-Presa MA, Ortego M, Tunon J, Ortega L, Perez F, et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabit model of atherosclerosis. J Am Coll Cardiol. 1998;32:2057-64.
67. Blanco-Colio LM, Tuñon J, Martín Ventura JL, Egido J. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int. 2003;63:12-23.
68. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M et al. Markers of infammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.